Skip to Content
Merck
  • Notch Cooperates with Survivin to Maintain Stemness and to Stimulate Proliferation in Human Keratinocytes during Ageing.

Notch Cooperates with Survivin to Maintain Stemness and to Stimulate Proliferation in Human Keratinocytes during Ageing.

International journal of molecular sciences (2015-11-06)
Elisabetta Palazzo, Paolo Morandi, Roberta Lotti, Annalisa Saltari, Francesca Truzzi, Sylvianne Schnebert, Marc Dumas, Alessandra Marconi, Carlo Pincelli
ABSTRACT

The Notch signaling pathway orchestrates cell fate by either inducing cell differentiation or maintaining cells in an undifferentiated state. This study aims to evaluate Notch expression and function in normal human keratinocytes. Notch1 is expressed in all epidermal layers, though to a different degree of intensity, with a dramatic decrease during ageing. Notch1 intracellular domain (N1ICD) levels are decreased during transit from keratinocyte stem cells (KSC) to transit amplifying (TA) cells, mimicking survivin expression in samples from donors of all ages. Calcium markedly reduces N1ICD levels in keratinocytes. N1ICD overexpression induces the up-regulation of survivin and the down-regulation of keratin 10 and involucrin, while increasing the S phase of the cell cycle. On the other hand, Notch1 inhibition (DAPT) dose-dependently decreases survivin, stimulates differentiation, and reduces keratinocyte proliferation in samples from donors of all ages. Silencing Notch downgrades survivin and increases keratin 10. In addition, Notch1 inhibition decreases survivin levels and proliferation both in KSC and TA cells. Finally, while survivin overexpression decreases keratinocyte differentiation and increases N1ICD expression both in KSC and TA cells, silencing survivin results in N1ICD down-regulation and an increase in differentiation markers. These results suggest that the Notch1/survivin crosstalk contributes to the maintenance of stemness in human keratinocytes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human IVL
Sigma-Aldrich
MISSION® esiRNA, targeting human NOTCH1
Sigma-Aldrich
MISSION® esiRNA, targeting human FIGN
Sigma-Aldrich
MISSION® esiRNA, targeting human VCL
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Birc5
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Notch1